(2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine
C84H97Cl2N3O8 — CID 159429693
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine
(2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine (PubChem CID 159429693) has the molecular formula C84H97Cl2N3O8 and a molecular weight of 1347.62 g/mol. Its IUPAC name is (2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine.
Molecular Properties
| Compound Name | (2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine |
|---|---|
| PubChem CID | 159429693 |
| Molecular Formula | C84H97Cl2N3O8 |
| Molecular Weight | 1347.62 g/mol |
| Exact Mass | 1345.67 |
| IUPAC Name | (2S)-2-(benzhydryloxymethyl)-1-[3-(4-methoxyphenyl)propyl]pyrrolidine;(2S)-2-[bis(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine;(2S)-2-[bis(4-methoxyphenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine |
| SMILES | COc1ccc(CCCN2CCC[C@H]2COC(c2ccccc2)c2ccccc2)cc1.COc1ccc(CCN2CCC[C@H]2COC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)cc1.COc1ccc(CCN2CCC[C@H]2COC(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 |
| InChI | InChI=1S/C29H35NO4.C28H33NO2.C27H29Cl2NO2/c1-31-26-12-6-22(7-13-26)18-20-30-19-4-5-25(30)21-34-29(23-8-14-27(32-2)15-9-23)24-10-16-28(33-3)17-11-24;1-30-27-18-16-23(17-19-27)10-8-20-29-21-9-15-26(29)22-31-28(24-11-4-2-5-12-24)25-13-6-3-7-14-25;1-31-26-14-4-20(5-15-26)16-18-30-17-2-3-25(30)19-32-27(21-6-10-23(28)11-7-21)22-8-12-24(29)13-9-22/h6-17,25,29H,4-5,18-21H2,1-3H3;2-7,11-14,16-19,26,28H,8-10,15,20-22H2,1H3;4-15,25,27H,2-3,16-19H2,1H3/t25-;26-;25-/m000/s1 |
| InChIKey | LQVDTHUGDUYTPG-BAAGHHFQSA-N |
| XLogP | 18.24 |
| TPSA | 83.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 97 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1347.62 |
| LogP ≤ 5 | 18.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159429693 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.